Pesquisas alternativas:
disease liver » disease like (Expandir a Pesquisa), disease linked (Expandir a Pesquisa), disease living (Expandir a Pesquisa)
does develop » boys develop (Expandir a Pesquisa), loss develop (Expandir a Pesquisa), does developing (Expandir a Pesquisa)
develop them » develop type (Expandir a Pesquisa), develop age (Expandir a Pesquisa)
drug disease » drug release (Expandir a Pesquisa)
level rather » levels rather (Expandir a Pesquisa), level rate (Expandir a Pesquisa), level catheter (Expandir a Pesquisa)
liver ther » liver other (Expandir a Pesquisa), live rather (Expandir a Pesquisa), liver thle2 (Expandir a Pesquisa)
drug noise » drug naive (Expandir a Pesquisa), drug nurse (Expandir a Pesquisa), during noise (Expandir a Pesquisa)
drug does » drug doses (Expandir a Pesquisa), drugs does (Expandir a Pesquisa), drug dose (Expandir a Pesquisa)
disease liver » disease like (Expandir a Pesquisa), disease linked (Expandir a Pesquisa), disease living (Expandir a Pesquisa)
does develop » boys develop (Expandir a Pesquisa), loss develop (Expandir a Pesquisa), does developing (Expandir a Pesquisa)
develop them » develop type (Expandir a Pesquisa), develop age (Expandir a Pesquisa)
drug disease » drug release (Expandir a Pesquisa)
level rather » levels rather (Expandir a Pesquisa), level rate (Expandir a Pesquisa), level catheter (Expandir a Pesquisa)
liver ther » liver other (Expandir a Pesquisa), live rather (Expandir a Pesquisa), liver thle2 (Expandir a Pesquisa)
drug noise » drug naive (Expandir a Pesquisa), drug nurse (Expandir a Pesquisa), during noise (Expandir a Pesquisa)
drug does » drug doses (Expandir a Pesquisa), drugs does (Expandir a Pesquisa), drug dose (Expandir a Pesquisa)
41
Por Csete, Joanne, Kamarulzaman, Adeeba, Kazatchkine, Michel, Altice, Frederick, Balicki, Marek, Buxton, Julia, Cepeda, Javier, Comfort, Megan, Goosby, Eric, Goulão, João, Hart, Carl, Horton, Richard, Kerr, Thomas, Lajous, Alejandro Madrazo, Lewis, Stephen, Martin, Natasha, Mejía, Daniel, Mathiesson, David, Obot, Isidore, Ogunrombi, Adeolu, Sherman, Susan, Stone, Jack, Vallath, Nandini, Vickerman, Peter, Zábranský, Tomáš, Beyrer, Chris
Publicado no Lancet (2016)
“... their health, human rights, and development impact. The Johns Hopkins – Lancet Commission on Drug Policy...”Publicado no Lancet (2016)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
42
“...) may affect normal gene expression and disease progression, making them a new class of targets for drug...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
43
Por Ranieri, Girolamo, Niccoli Asabella, Artor, Altini, Corinna, Fazio, Vito, Caporusso, Luciana, Marech, Ilaria, Vinciarelli, Gianluca, Macina, Francesco, de Ceglia, Dario, Fanelli, Margherita, Ammendola, Michele, Rubini, Giuseppe, Gadaleta, Cosmo Damiano
Publicado no Onco Targets Ther (2016)
“...BACKGROUND: The main aim of this prospective study was to evaluate the efficacy of drug-eluting...”Publicado no Onco Targets Ther (2016)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
44
Por Siemianowicz, Krzysztof, Likus, Wirginia, Dorecka, Mariola, Wilk, Renata, Dziubdziela, Włodzimierz, Markowski, Jarosław
Publicado no Biomed Res Int (2018)
“... technologies for provision of pharmaceutical forms of them, including drug nanocarriers, are currently underway...”Publicado no Biomed Res Int (2018)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
45
Por Krzysztof Siemianowicz, Wirginia Likus, Mariola Dorecka, Renata Wilk, Włodzimierz Dziubdziela, Jarosław Markowski
Publicado em 2018-01-01
“... technologies for provision of pharmaceutical forms of them, including drug nanocarriers, are currently underway...”Publicado em 2018-01-01
Obter o texto integral
Artigo
46
Por Zhang, Ran-Ran, Zheng, Yun-Wen, Li, Bin, Nie, Yun-Zhong, Ueno, Yasuharu, Tsuchida, Tomonori, Taniguchi, Hideki
Publicado no Stem Cell Res Ther (2018)
“... repopulated over 90% of the mouse liver and differentiated into functional hepatocytes with drug metabolism...”Publicado no Stem Cell Res Ther (2018)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
47
“... evaluation in patients with resectable or unresectable liver-limited (+/- lung) disease....”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
48
“...CML is a clonal multistep myeloproliferative disease originating from and ultimately sustained by a...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
49
“... nature of the disease process makes BPD a challenging condition to treat. While multiple pharmacologic...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
50
Por López-Riera, Mireia, Conde, Isabel, Tolosa, Laia, Zaragoza, Ángela, Castell, José V., Gómez-Lechón, María J., Jover, Ramiro
Publicado no Front Pharmacol (2017)
“... be particularly relevant in non-alcoholic fatty liver disease (NAFLD), where most patients show features...”Publicado no Front Pharmacol (2017)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
51
Por Akinc, Akin, Goldberg, Michael, Qin, June, Dorkin, J Robert, Gamba-Vitalo, Christina, Maier, Martin, Jayaprakash, K Narayanannair, Jayaraman, Muthusamy, Rajeev, Kallanthottathil G, Manoharan, Muthiah, Koteliansky, Victor, Röhl, Ingo, Leshchiner, Elizaveta S, Langer, Robert, Anderson, Daniel G
Publicado em 2009
“..., thereby blocking production of disease-causing proteins. The development of safe and effective systemic...”Publicado em 2009
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
52
Por John Leonardo Torres-Castiblanco, Jorge Alberto Carrillo, Daniel Hincapié-Urrego, Adriana Rojas-Villarraga
Publicado no Biomédica (2018)
“... of rheumatoid arthritis, among them, the first line of disease-modifying antirheumatic drugs (DMARD), and novel...”Publicado no Biomédica (2018)
Obter o texto integral
Artigo
53
Por Kyttaris, Vasileios C
Publicado em 2012
“... decades with the use of disease-modifying antirheumatic drugs. However, despite the use of methotrexate...”Publicado em 2012
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
54
“... and fewer side effects are under development. Some of them are being clinically tested in the contexts...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
55
Por Parolin, Micol, Simonelli, Alessandra, Mapelli, Daniela, Sacco, Marianna, Cristofalo, Patrizia
Publicado no Front Psychol (2016)
“...Parental substance use is a major risk factor for child development, heightening the risk of drug...”Publicado no Front Psychol (2016)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
56
Por Sun, Ya-Zhou, Zhang, De-Hong, Cai, Shu-Bin, Ming, Zhong, Li, Jian-Qiang, Chen, Xing
Publicado no Front Cell Infect Microbiol (2018)
“... and behavior and is closely related to the occurrence and development of disease. Although the diversity...”Publicado no Front Cell Infect Microbiol (2018)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
57
“... advances in the development of multifunctional polymeric micelles specifically for delivery of drugs...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
58
Por Corrà, Fabio, Agnoletto, Chiara, Minotti, Linda, Baldassari, Federica, Volinia, Stefano
Publicado no Front Oncol (2018)
“..., plays an ever-increasing role in cancer development. ncRNAs, including notorious microRNAs, have been...”Publicado no Front Oncol (2018)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
59
Por Douglass, Alyse N, Kain, Heather S, Abdullahi, Marian, Arang, Nadia, Austin, Laura S, Mikolajczak, Sebastian A, Billman, Zachary P, Hume, Jen C C, Murphy, Sean C, Kappe, Stefan H I, Kaushansky, Alexis
Publicado no Mol Ther (2015)
“... would stop disease and subsequent transmission. Unfortunately, only a single licensed drug that targets...”Publicado no Mol Ther (2015)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
60
Por Li, Wen-Jie, Lian, You-Wen, Guan, Quan-Sheng, Li, Ning, Liang, Wen-Jun, Liu, Wen-Xin, Huang, Yong-Bin, Cheng, Yi, Luo, Hui
Publicado no Exp Ther Med (2018)
“...Liver-targeted drug delivery improves the efficacy of anti-liver cancer agents and reduces systemic...”Publicado no Exp Ther Med (2018)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo